(IN BRIEF) From Bonn to Bilbao, Europe’s AI scene is buzzing with innovation. Major players like Deutsche Telekom, Ericsson, and Volkswagen are pushing boundaries through groundbreaking partnerships and integrations. Projects like NextGen are personalizing therapies using AI, while collaborations between … Read the full press release
Posted in Artificial Intelligence (AI), Automotive, Banks, Business, Financial, France, Germany, Healthcare, Internet & Online, Ireland, Netherlands, Pharma & Biotech, Romania, Science, Security & Safety, Spain, Switzerland, Technology, Telecom, United Kingdom
Tagged 5G services, ABB, Accenture, AI, AI IN JAN 2024, AI innovation, AI safety, AI solutions, AI Supercomputers, AI-powered assistants, AI-Powered MBUX Virtual Assistant, Aurora Labs, aws, BBVA, ChatGPT, Deutsche Telekom, Ericsson, Europe's AI scene, Fetch.ai, generative AI, Infineon, Ipsotek, Laura voice assistant, Mercedes-Benz, Meshmind, NextGen, NVIDIA, QuantHealth, Siemens, ŠKODA AUTO, Swisscom, The AI Governance Alliance, Volkswagen
(IN BRIEF) GSK plc has announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for bepirovirsen, an investigational antisense oligonucleotide (ASO) targeting chronic hepatitis B (CHB). The Fast Track designation aims to expedite the development … Read the full press release
Posted in Business, Education, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Bepirovirsen, Chronic Hepatitis B Treatment, FDA Fast Track, GSK
(IN BRIEF) In a Phase III trial conducted in Japan, acoramidis, an investigational treatment for transthyretin-mediated amyloid cardiomyopathy (ATTR-CM), demonstrated promising high-level results consistent with the global BridgeBio Pharma, Inc. ATTRibute-CM Phase III trial. The trial in Japan aimed to … Read the full press release
Posted in Business, Education, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Acoramidis, AstraZeneca, Japan, Marc Dunoyer, Professor Yukio Ando, Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM), treatment
(IN BRIEF) Novonesis, the merger of Novozymes and Chr. Hansen, is now officially completed, solidifying its position as a global leader in biosolutions. With over 10,000 employees worldwide and expertise spanning 30 industries, Novonesis aims to provide biosolutions that benefit … Read the full press release
Posted in Business, Denmark, Management, Pharma & Biotech, Technology
Tagged biosolutions, Cees de Jong, Chr. Hansen, Ester Baiget, Novonesis, Novozymes, statutory merger
(IN BRIEF) GSK has received marketing authorization from the European Commission for Omjjara (momelotinib), an oral inhibitor targeting JAK1/JAK2 and activin A receptor type 1 (ACVR1). Omjjara is the first approved treatment in the EU for disease-related splenomegaly (enlarged spleen) … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Francesca Palandri, GSK, Myelofibrosis Treatment, Nina Mojas, Omjjara, splenomegaly
(IN BRIEF) GSK has submitted a regulatory application to the European Medicines Agency (EMA) to expand the use of its adjuvanted recombinant respiratory syncytial virus (RSV) vaccine to adults aged 50-59 who are at increased risk for RSV disease. The … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Adults Aged 50-59, COPD, GSK, NCT05590403, RSV Vaccination, vaccine
(IN BRIEF) E. Merck KG, representing the Merck family’s interests in Merck KGaA, has disclosed the results of its regular board elections. Johannes Baillou, with 30 years of board experience at E. Merck KG, has been elected as Chairman of … Read the full press release
Posted in Business, Germany, Healthcare, Industrial, Management, News, Pharma & Biotech, Science, Technology
Tagged André Wyss, appointment, Carl Christoph Schweickert, Dr Wolfgang Büchele, Dr. Daniel Thelen, Dr. Frank Stangenberg-Haverkamp, Dr. Katharina Kraft, Dr. Susanne Schaffert, E. Merck KG, Family Board Elections, Johannes Baillou, leadership, Merck, Michael Kleinemeier, Professor Dr. Simon Thelen
(IN BRIEF) Merck, a leading science and technology company, has inaugurated the Merck Digital Hub in Singapore, its first digital hub outside of the US and Europe. Supported by the Singapore Economic Development Board (EDB), the hub aims to accelerate … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Athinia™, Digital Hub, Healthcare, Laura Matz, Merck, partnership, Semiconductor Innovation, Singapore, Singapore Economic Development Board (EDB), sustainability, Syntropy™, Wan Yee Goh
(IN BRIEF) The U.S. Food and Drug Administration (FDA) has granted approval for Dupixent® (dupilumab) to treat pediatric patients aged 1 to 11 years, weighing at least 15 kg, who suffer from eosinophilic esophagitis (EoE). Dupixent is now the first … Read the full press release
Posted in Business, Education, Financial, France, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged dupilumab, Dupixent, Eosinophilic Esophagitis (EoE) Treatment, FDA approval, George D. Yancopoulos, Naimish Patel, pediatric, Regeneron, Sanofi
(IN BRIEF) BioNTech and Duality Biologics have announced the commencement of a pivotal Phase 3 trial for BNT323/DB-1303, a next-generation antibody-drug conjugate (ADC) targeting the Human Epidermal Growth Factor Receptor 2 (HER2) in metastatic breast cancer. The trial will enroll … Read the full press release
(IN BRIEF) The Japanese Ministry of Health, Labour and Welfare (MHLW) has granted approval for Voydeya (danicopan), a groundbreaking oral Factor D inhibitor, for the treatment of paroxysmal nocturnal haemoglobinuria (PNH). Voydeya is indicated in Japan for use in combination … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged AstraZeneca, Innovative Treatment, Japan, Marc Dunoyer, Paroxysmal Nocturnal Haemoglobinuria (PNH), Professor Jun-ichi Nishimura, Voydeya (danicopan)
(IN BRIEF) Basilea Pharmaceutica Ltd (SIX: BSLN) has announced that its partner Knight Therapeutics Inc. (TSX: GUD) exceeded the sales threshold for the antifungal Cresemba (isavuconazole) in Latin America in 2023, triggering the first sales milestone payment for the region. … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged antifungal, Basilea, Cresemba®, David Veitch, Knight Therapeutics, Latin America, partnership, sustainability
(IN BRIEF) Boehringer Ingelheim has been honored by the Top Employers Institute with a “Global Top Employer” certification for the fourth consecutive year, distinguishing it as one of only 17 globally certified companies. The recognition is attributed to the company’s … Read the full press release
Posted in Awards, Business, Germany, Industrial, Management, News, Pharma & Biotech
Tagged Awards, Boehringer Ingelheim, Employee Development, Global Top Employer, Sven Sommerlatte, wellbeing
(IN BRIEF) Onera Health, a leader in sleep diagnostic and monitoring solutions, has successfully completed a €30 million ($32 million) Series C financing round. The funding was led by EQT Life Sciences and co-led by Gimv, with participation from existing … Read the full press release
(IN BRIEF) Empa researchers have developed an innovative technique using nanoparticles for soldering wounds, potentially revolutionizing wound closure methods. This groundbreaking approach offers precise temperature control and can be applied in minimally invasive surgery. The nanoparticles enable gentle laser soldering, … Read the full press release
(IN BRIEF) Basilea Pharmaceutica Ltd (SIX: BSLN), a biopharmaceutical company specializing in severe bacterial and fungal infection treatments, has announced an asset purchase agreement with Spexis AG (SIX: SPEX) for a preclinical antibiotics program aimed at combating Gram-negative bacteria, including … Read the full press release
(IN BRIEF) Evonik has been awarded the Responsible Care® Award by the European Chemical Industry Council (Cefic) in the “Safe and Sustainable Chemicals” category for its innovative glycolipid biosurfactants platform. The company’s glycolipid biosurfactants, developed using biotechnology, are recognized for … Read the full press release
(IN BRIEF) Accenture has announced a strategic investment through Accenture Ventures in QuantHealth, an AI-powered clinical trial design company specializing in cloud-based simulations for pharmaceutical and biotech companies. Using AI technology trained on extensive patient data and clinical trial information, … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Ireland, Management, News, Pharma & Biotech, Science, Technology
Tagged Accenture, Accenture Ventures, AI technology, investment, Israel, Orr Inbar, partnership, Petra Jantzer, QuantHealth, sustainability, Tom Lounibos, USA
(IN BRIEF) The global life sciences industry has witnessed a resurgence in mergers and acquisitions (M&A) activity, with investments totaling $191 billion by December 10, 2023, compared to $142 billion in 2022. Although the number of completed deals decreased, the … Read the full press release
(IN BRIEF) Merck KGaA, Darmstadt, Germany, has entered into a licensing agreement with Inspirna, Inc. for ompenaclid (RGX-202), a first-in-class oral inhibitor of the creatine transport channel SLC6A8, and SLC6A8-targeting follow-on compounds, currently under Phase II evaluation for the second-line … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged colorectal cancer, Dr. Usman “Oz” Azam, ERBITUX, Inspirna, Merck KGaA, ompenaclid (RGX-202), partnership, sustainability, USA, Victoria Zazulina
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?